ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN
OFFICERS.
On August 21, 2012, Celgene Corporation (the "Company") announced that,
effective September 1, 2012, Graham Burton, MBBS, FRCP, will relinquish his
responsibilities as Senior Vice President Global Regulatory Affairs,
Pharmacovigilance, Corporate Quality and Compliance. In his transition to
retirement, Dr. Burton will take on new assignments that capitalize on his
extensive global expertise and worldwide stakeholder relationships.
Add
CELG to Portfolio
Set Alert
Email to a
Friend